Clin2
NCT07555743Possibly a fitNot yet recruiting

Sleep drug test for people with depression and insomnia

InsomniaMajor Depressive Disorder

Treatments studied

Part of Brain & nervous system, Mental health clinical trials.

This study tests an experimental sleep aid called daridorexant for people who have both depression and insomnia. It aims to see if the drug can improve sleep without worsening depression symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
134 people
Ages
18 years to 99 years
Study type
Interventional

Who can take part

  • You are between 18 and 99 years old.
  • You have been diagnosed with depression that is currently moderate or severe.
  • You have insomnia that is confirmed and significant.
  • Your depression medication (if any) has been the same for at least a month.
  • You are willing to stop certain sleep medications (like melatonin or benzodiazepines) before starting.
  • You are not pregnant or breastfeeding, and have no uncontrolled serious medical conditions.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07847021Not yet recruiting
Daridorexant for adults with insomnia

This study follows adults with insomnia who are prescribed a new sleep medication called daridorexant. It aims to see how well the medication works in a real-world setting, and to monitor its safety and effects on sleep.

Chaohu, Anhui
NCT07701928Not yet recruiting· Phase 2
Sleep medication for insomnia and alcohol use disorder

This study tests a sleep medication called daridorexant to see if it helps people with both insomnia and alcohol use disorder sleep better and reduce drinking. It may offer a new way to address both problems together.

Spokane, Washington
NCT07328594Not yet recruiting· Phase 4
Sleep medication study for smokers wanting to cut back

This study tests a sleep medication called daridorexant to see if it helps smokers sleep better and feel more alert during the day, which might make it easier to cut back on smoking. You'll take the medication for 3 weeks and track your sleep and smoking at home.

Portland, Oregon
NCT07392177Recruiting· Phase 2
Understanding the brain's role in insomnia

This trial tests whether a part of the brain called the locus coeruleus is involved in insomnia. It involves sleep questionnaires and possibly brain imaging to understand your sleep problems better.

Macquarie Park, New South Wales
NCT07255027Not yet recruiting
Anesthesia-induced sleep therapy for long-term insomnia

This study tests a sleep treatment given under anesthesia to help people with severe, long-lasting insomnia that hasn't improved with other treatments. It looks at whether this approach is safe and effective for improving sleep and daytime function.

NCT07542756Recruiting· Phase 4
Testing Common Sleep Medications for Insomnia

This study compares how well different over-the-counter and prescription sleep medications work for insomnia. Researchers will guide you through trying medications one at a time to find what works best for your sleep problems.

Philadelphia, Pennsylvania

Hear when a new Insomnia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.